Osaic Holdings’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.46K Buy
262
+176
+205% +$1.67K ﹤0.01% 7213
2026
Q1
$807 Hold
86
﹤0.01% 7321
2025
Q4
$699 Hold
86
﹤0.01% 7370
2025
Q3
$1.04K Sell
86
-39
-31% -$371 ﹤0.01% 7333
2025
Q2
$800 Buy
125
+36
+40% +$262 ﹤0.01% 7225
2025
Q1
$472 Buy
89
+76
+585% +$671 ﹤0.01% 7001
2024
Q4
$153 Sell
13
-73
-85% -$1.22K ﹤0.01% 7200
2024
Q3
$1.77K Hold
86
﹤0.01% 6663
2024
Q2
$3.89K Buy
86
+56
+187% +$2.35K ﹤0.01% 6296
2024
Q1
$1.18K Sell
30
-216
-88% -$5.33K ﹤0.01% 6642
2023
Q4
$1.49K Sell
246
-185
-43% -$993 ﹤0.01% 6637
2023
Q3
$2.9K Buy
431
+198
+85% +$1.37K ﹤0.01% 6484
2023
Q2
$1.83K Sell
233
-103
-31% -$926 ﹤0.01% 6697
2023
Q1
$2.44K Buy
336
+112
+50% +$490 ﹤0.01% 6633
2022
Q4
$255 Buy
224
+42
+23% +$162 ﹤0.01% 7104
2022
Q3
$1K Hold
182
﹤0.01% 6956
2022
Q2
$1K Buy
182
+9
+5% +$87 ﹤0.01% 7049
2022
Q1
$2K Buy
173
+64
+59% +$848 ﹤0.01% 6860
2021
Q4
$2K Buy
109
+22
+25% +$596 ﹤0.01% 6990
2021
Q3
$3K Sell
87
-40
-31% -$1.58K ﹤0.01% 6721
2021
Q2
$6K Hold
127
﹤0.01% 6286
2021
Q1
$7K Buy
127
+30
+31% +$1.97K ﹤0.01% 6015
2020
Q4
$3K Sell
97
-114
-54% -$4.26K ﹤0.01% 5936
2020
Q3
$25K Sell
211
-85
-29% -$15.4K ﹤0.01% 4776
2020
Q2
$73K Buy
296
+102
+53% +$20.6K ﹤0.01% 3911
2020
Q1
$30K Buy
+194
New +$32.8K ﹤0.01% 4355

Other funds holding CRBP

Osaic Holdings's CRBP Position: Q2 2026 in Review

Osaic Holdings increased its Corbus Pharmaceuticals (CRBP) stake by 205% in Q2 2026, buying an estimated $1.67K and bringing the position to 262 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #7213.

Osaic Holdings first reported a position in CRBP in Q1 2020 and has held it in 26 quarters since. The position peaked at $73K in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Osaic Holdings held 262 shares of Corbus Pharmaceuticals worth $2.46K as of Q2 2026.
  • Osaic Holdings bought 176 Corbus Pharmaceuticals shares in Q2 2026, an estimated $1.67K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7213 holding.
  • Osaic Holdings first reported a position in Corbus Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Corbus Pharmaceuticals position peaked at $73K in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.